BTAI Stock Price | BioXcel Therapeutics Inc. Stock Quote (U.S.: …

4 days ago · BioXcel Therapeutics price target cut to $127 from $150 at Truist Securities, stock rated buy. Apr. 1, 2021 at 6:59 a.m. ET by Tonya Garcia.

CouponFollow Extension

$127
OFF

BTAI Stock Price | BioXcel Therapeutics Inc. Stock Quote (U.S.: …

6 days from now

4 days ago · BioXcel Therapeutics price target cut to $127 from $150 at Truist Securities, stock rated buy. Apr. 1, 2021 at 6:59 a.m. ET by Tonya Garcia.

marketwatch.com

$60
OFF

BioXcel Therapeutics (BTAI) Stock Price, News & Analysis

6 days from now

1 day ago · BioXcel Therapeutics (BTAI) raised $60 million in an initial public offering on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 …

marketbeat.com

$0.58
OFF

BioXcel Therapeutics Stock Price | BTAI Stock Quote, News, And …

6 days from now

Discover the best brokers for stock trading and ordering other assets! On Wednesday 11/20/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.58 on BTT. …

businessinsider.com

79%
OFF

BioXcel Therapeutics, Inc. (BTAI) Historical Stock Price Data - Stock ...

6 days from now

5 days ago · 1.28. 1.28. 0.79%. 3,123,765. Previous. Page 1 of 3. 100 Rows. Back to Top ↑. Get a complete stock price history for BioXcel Therapeutics, starting from its first trading day.

stockanalysis.com

$5.00
OFF

BioXcel Therapeutics (BTAI) Stock Forecast & Price Target

6 days from now

4 days ago · Consensus Price Target. According to the 4 analysts' twelve-month price targets for BioXcel Therapeutics, the average price target is $5.00. The highest price target for BTAI is …

marketbeat.com

$13
OFF

BioXcel Therapeutics Reports Third Quarter 2024 Financial Results

6 days from now

Nov 14, 2024 · NetLoss:BioXcel Therapeutics had a net loss of $13.7 million for the third quarter of 2024, compared to a net loss of $50.5 million for the same period in 2023. The Company …

yahoo.com

$13
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 15, 2024 · The company reported a net loss of $13.7 million for Q3 2024, although this was an improvement from a $50.5 million loss in Q3 2023. Cost of goods sold increased …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 ... - Markets Insider

6 days from now

1 day ago · Nov. 22, 2024, 08:16 AM. NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company …

businessinsider.com

$0.50
OFF

BioXcel Therapeutics Inc (BTAI) Stock Price, Quote, AI Analysis

6 days from now

Nov 2, 2024 · The BioXcel stock price range over the past 12 months has been $0.50 - $5.62. What is going on with BioXcel stock in the last 3 months? The BioXcel stock performance in …

danelfin.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

globenewswire.com

$1
OFF

BioXcel Therapeutics (BTAI) - Zacks Investment Research

6 days from now

4 days ago · The current on short-term price targets is based on 2 reports. The forecasts for BioXcel Therapeutics, Inc. (BTAI) range from a low of $1 to a high of $7. The average price …

zacks.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics GAAP EPS of -$0.32 …

msn.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

1 day ago · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript. BioXcel announces common stock and warrants offering, no amount given. BioXcel Therapeutics …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

FAQs about BTAI Stock Price | BioXcel Therapeutics Inc. Stock Quote (U.S.: … Coupon?

Who owns bioxcel Therapeutics (btai)?

It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT. View BioXcel Therapeutics, Inc. BTAI stock quote prices, financial information, real-time forecasts, and company news from CNN. ...

Who owns bioxcel Therapeutics Inc?

It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT. BTAI | Complete BioXcel Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Does bioxcel Therapeutics (btai) have earnings?

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) reported earnings on Thursday, May, 9th. The company reported ($0.87) EPS, missing analysts' consensus estimates of ($0.68) by $0.19. The business earned $0.58 million during the quarter, compared to the consensus estimate of $0.42 million. ...

What are the share price targets for BTAI?

The share price targets for BTAI range from $4.00 to $40.00. On average, analysts anticipate the company's stock price to reach $16.71 in the next year. This suggests a possible upside of 925.4% from the stock's current price. ...

Where can I buy BTAI stock?

BTAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. ...

What does btai stand for?

BioXcel Therapeutics Inc (BTAI) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue ... BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. ...